Baylor Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 3.02 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Baylor Pharmaceutical
Baylor Pharmaceutical Private Limited (BPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 May 2019 (Five years and eight months 19 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.02 M, as per Ministry of Corporate Affairs (MCA) records.
Panni Prashob, Edadan Suhesh, Kandamkulngara Aneesh, and Three other members serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85110MH2019PTC326121
-
Company No.
326121
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 May 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Baylor Pharmaceutical?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Panni Prashob
|
Director | 02-Mar-2021 | Current |
|
Edadan Suhesh
|
Director | 01-May-2021 | Current |
|
Kandamkulngara Aneesh
|
Director | 22-May-2021 | Current |
|
Kalathilparambath Sujil
|
Director | 15-Dec-2023 | Current |
|
Anoop Murali
|
Director | 15-Dec-2023 | Current |
|
Cheruliyil Das
|
Director | 15-Dec-2023 | Current |
Financial Performance of Baylor Pharmaceutical.
Enhance accessibility to Baylor Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baylor Pharmaceutical?
Unlock access to Baylor Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Baylor Pharmaceutical?
Unlock and access historical data on people associated with Baylor Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baylor Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baylor Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
